Mitsune Tanimoto

18.8k total citations
525 papers, 13.7k citations indexed

About

Mitsune Tanimoto is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Mitsune Tanimoto has authored 525 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Oncology, 211 papers in Pulmonary and Respiratory Medicine and 128 papers in Hematology. Recurrent topics in Mitsune Tanimoto's work include Lung Cancer Treatments and Mutations (133 papers), Lung Cancer Research Studies (93 papers) and Hematopoietic Stem Cell Transplantation (57 papers). Mitsune Tanimoto is often cited by papers focused on Lung Cancer Treatments and Mutations (133 papers), Lung Cancer Research Studies (93 papers) and Hematopoietic Stem Cell Transplantation (57 papers). Mitsune Tanimoto collaborates with scholars based in Japan, United States and Greece. Mitsune Tanimoto's co-authors include Katsuyuki Kiura, Masahiro Tabata, Hiroshi Ueoka, Katsuyuki Hotta, Nagio Takigawa, Hidehiko Saito, Keitaro Matsuo, Masayuki Towatari, Mine Harada and Eiki Ichihara and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Mitsune Tanimoto

515 papers receiving 13.4k citations

Peers

Mitsune Tanimoto
Massimo Aglietta Italy
Jacqueline Whang‐Peng Taiwan
Ingo G.H. Schmidt‐Wolf Germany
Christian Peschel Germany
Alexandar Tzankov Switzerland
Janice P. Dutcher United States
Svetomir N. Markovic United States
Falko Fend Germany
Anne Janin France
Giulio Rossi Italy
Massimo Aglietta Italy
Mitsune Tanimoto
Citations per year, relative to Mitsune Tanimoto Mitsune Tanimoto (= 1×) peers Massimo Aglietta

Countries citing papers authored by Mitsune Tanimoto

Since Specialization
Citations

This map shows the geographic impact of Mitsune Tanimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsune Tanimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsune Tanimoto more than expected).

Fields of papers citing papers by Mitsune Tanimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsune Tanimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsune Tanimoto. The network helps show where Mitsune Tanimoto may publish in the future.

Co-authorship network of co-authors of Mitsune Tanimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsune Tanimoto. A scholar is included among the top collaborators of Mitsune Tanimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsune Tanimoto. Mitsune Tanimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harada, Miyuki, Chisato Kunitomi, Gentaro Izumi, et al.. (2019). A Japanese nationwide survey on the cryopreservation of embryos, oocytes and ovarian tissue for cancer patients. Journal of obstetrics and gynaecology research. 45(10). 2021–2028. 16 indexed citations
3.
Taniguchi, Akihiko, Nobuaki Miyahara, Naohiro Oda, et al.. (2017). Protective Effects of Bisoprolol against Acute Exacerbation in Moderate-to-Severe Chronic Obstructive Pulmonary Disease.. PubMed. 71(5). 453–457. 4 indexed citations
4.
Isozaki, Hideko, Eiki Ichihara, Nagio Takigawa, et al.. (2016). Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases. Cancer Research. 76(6). 1506–1516. 109 indexed citations
5.
Hotta, Katsuyuki, Jiichiro Sasaki, Sho Saeki, et al.. (2015). Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non–Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol. Clinical Lung Cancer. 17(1). 75–79. 11 indexed citations
6.
Kimura, Fumiaki, et al.. (2013). Development And Evaluation Of A Quantitative Lateral Flow Immunoassay For The Detection Of Ferritin As Point-of-care Testing. American Journal of Hematology. 88(5). 1 indexed citations
7.
Ninomiya, Takashi, Nagio Takigawa, Eiki Ichihara, et al.. (2013). Afatinib Prolongs Survival Compared with Gefitinib in an Epidermal Growth Factor Receptor-Driven Lung Cancer Model. Molecular Cancer Therapeutics. 12(5). 589–597. 54 indexed citations
8.
Minami, Daisuke, Nagio Takigawa, Minoru Takata, et al.. (2012). Synergistic Effect of Olaparib with Combination of Cisplatin on PTEN -Deficient Lung Cancer Cells. Molecular Cancer Research. 11(2). 140–148. 50 indexed citations
9.
Rai, Kammei, Nagio Takigawa, Sachio Ito, et al.. (2011). Liposomal Delivery of MicroRNA-7–Expressing Plasmid Overcomes Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Resistance in Lung Cancer Cells. Molecular Cancer Therapeutics. 10(9). 1720–1727. 110 indexed citations
10.
Nishimori, Hisakazu, Shunji Takahashi, Katsuyuki Kiura, et al.. (2010). Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan.. PubMed. 64(5). 285–91. 5 indexed citations
11.
Ohashi, Kadoaki, Nagio Takigawa, Eiki Ichihara, et al.. (2009). Chemopreventive Effects of Gefitinib on Nonsmoking-Related Lung Tumorigenesis in Activating Epidermal Growth Factor Receptor Transgenic Mice. Cancer Research. 69(17). 7088–7095. 17 indexed citations
12.
Oze, Isao, Keitaro Matsuo, Takeshi Suzuki, et al.. (2009). Impact of Multiple Alcohol Dehydrogenase Gene Polymorphisms on Risk of Upper Aerodigestive Tract Cancers in a Japanese Population. Cancer Epidemiology Biomarkers & Prevention. 18(11). 3097–3102. 54 indexed citations
13.
Oka, Takashi, Kana Washio, Masayuki Takano, et al.. (2009). Multi-Step Aberrant CpG Island Hyper-Methylation Is Associated with the Progression of Adult T–Cell Leukemia/Lymphoma. American Journal Of Pathology. 176(1). 402–415. 58 indexed citations
14.
Ichihara, Eiki, Kadoaki Ohashi, Nagio Takigawa, et al.. (2008). Emergence of the EGFR T790M mutation in a lung adenocarcinoma cell line after vandetanib treatment. Cancer Research. 68. 678–678.
15.
Tanaka, Hisaaki, Kiyoshi Yanagisawa, Keiko Shinjo, et al.. (2007). Lineage-Specific Dependency of Lung Adenocarcinomas on the Lung Development Regulator TTF-1. Cancer Research. 67(13). 6007–6011. 165 indexed citations
16.
Hisamoto, Akiko, Eisei Kondo, Katsuyuki Kiura, et al.. (2005). Profile of phospho-proteins according to LKB1 gene status in lung cancer cells. Cancer Research. 65. 1348–1348. 1 indexed citations
17.
Tokumo, Masaki, Shinichi Toyooka, Katsuyuki Kiura, et al.. (2005). The relationship between epidermal growth factor receptor(EGFR) mutations and clinico-pathological features in non-small cell lung cancers. Cancer Research. 65. 393–393. 2 indexed citations
18.
Iida, Hiroatsu, Masayuki Towatari, Minako Iida, et al.. (2000). Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBP beta in acute myeloid leukemia blasts.. PubMed. 71(2). 153–8. 14 indexed citations
19.
Akatsuka, Yoshiki, Nobuhiko Emi, Hidefumi Kato, et al.. (1994). Retrovirus-mediated transfer of a hygromycin phosphotransferase-thymidine kinase fusion gene into human CD34+ bone marrow cells.. PubMed. 60(4). 251–61. 4 indexed citations
20.
Tanimoto, Mitsune, Tetsuhito Kojima, Motohiro Hamaguchi, et al.. (1989). Extragenic factor IX gene RFLP is useful for detecting carriers of Japanese hemophilia B.. PubMed. 52(4). 774–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Aglietta Breakdown of academic impact, for papers by Jacqueline Whang‐Peng Breakdown of academic impact, for papers by Ingo G.H. Schmidt‐Wolf Breakdown of academic impact, for papers by Christian Peschel Breakdown of academic impact, for papers by Alexandar Tzankov Breakdown of academic impact, for papers by Janice P. Dutcher Breakdown of academic impact, for papers by Svetomir N. Markovic Breakdown of academic impact, for papers by Falko Fend Breakdown of academic impact, for papers by Anne Janin Breakdown of academic impact, for papers by Giulio Rossi
Rankless by CCL
2026